We agree with the applicant that the TOPS TM System meets the cost criterion and are therefore proposing to approve the TOPS TM System for new technology add-on payments for FY 2024, subject to the technology receiving FDA marketing authorization as a Breakthrough Device for the indication corresponding to the Breakthrough Device designation by July 1, 2023
p300/CBP lysine lactyltransferases The histone acetyltransferases (HATs) p300 and CBP (KAT3B/KAT3A) are large multidomain enzymes whose catalytic HAT domains can promiscuously accommodate various acyl-CoA substrates [47]
In this study, we combined genome-wide in silico analyses with molecular, biochemical, metabolic, and physiological approaches to explore how the glyoxalase system contributes to salinity stress adaptation in Artemisia annua
Reduced mortality after allogeneic hematopoietic-cell transplantation
These findings suggest the presence of ferroptosis, inflammatory imbalance, and endothelial dysfunction in PE patients